abstract |
Disclosed is a therapeutic agent for at least one disease selected from the group consisting of epilepsy, bipolar disorder, and neuropathic pain. (2S) -2-[(4S) -4- (2,2-difluorovinyl) -2-oxopyrrolidinyl] butanamide or a pharmaceutically acceptable salt thereof, and a pharmaceutical thereof use. [Selection figure] None |